Healthequity Stock Cash And Equivalents
| 2HE Stock | EUR 90.50 1.50 1.69% |
Healthequity fundamentals help investors to digest information that contributes to Healthequity's financial success or failures. It also enables traders to predict the movement of Healthequity Stock. The fundamental analysis module provides a way to measure Healthequity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Healthequity stock.
Healthequity |
Healthequity Company Cash And Equivalents Analysis
Healthequity's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Healthequity Cash And Equivalents | 329.31 M |
Most of Healthequity's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Healthequity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, Healthequity has 329.31 M in Cash And Equivalents. This is 73.63% lower than that of the Technology sector and 291.41% higher than that of the Health Information Services industry. The cash and equivalents for all Germany stocks is 87.81% higher than that of the company.
Healthequity Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Healthequity's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Healthequity could also be used in its relative valuation, which is a method of valuing Healthequity by comparing valuation metrics of similar companies.Healthequity is rated fifth in cash and equivalents category among its peers.
Healthequity Fundamentals
| Return On Equity | -0.0313 | |||
| Return On Asset | 0.0037 | |||
| Profit Margin | (0.07) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 5.61 B | |||
| Shares Outstanding | 84.64 M | |||
| Shares Owned By Insiders | 1.96 % | |||
| Shares Owned By Institutions | 98.04 % | |||
| Price To Earning | 48.79 X | |||
| Price To Book | 2.82 X | |||
| Price To Sales | 6.20 X | |||
| Revenue | 756.56 M | |||
| Gross Profit | 423.71 M | |||
| EBITDA | 107.02 M | |||
| Net Income | (44.29 M) | |||
| Cash And Equivalents | 329.31 M | |||
| Cash Per Share | 5.25 X | |||
| Total Debt | 922.08 M | |||
| Debt To Equity | 7.50 % | |||
| Current Ratio | 15.60 X | |||
| Book Value Per Share | 22.25 X | |||
| Cash Flow From Operations | 141 M | |||
| Earnings Per Share | (0.66) X | |||
| Price To Earnings To Growth | 1.91 X | |||
| Target Price | 85.5 | |||
| Number Of Employees | 3.69 K | |||
| Beta | 0.77 | |||
| Market Capitalization | 5.19 B | |||
| Total Asset | 3.11 B | |||
| Z Score | 3.0 | |||
| Net Asset | 3.11 B |
About Healthequity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Healthequity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Healthequity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Healthequity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Healthequity Stock
When determining whether Healthequity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Healthequity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Healthequity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Healthequity Stock please use our How to Invest in Healthequity guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.